Current treatments for diabetes often rely on injections of GLP-1 medications, a process that can be burdensome for individuals. Researchers are actively pioneering advanced release systems to optimize person compliance and outcomes. These include ingested formulations, through the nose delivery, and even long-acting devices, offering a more conven

New Evidence Shows 22.8% Weight Loss in Long-term Study The SURMOUNT-4 trial has shown remarkable results for eco-friendly weight management. Our analysis of this landmark study reveals that participants lost an impressive 25.3% of their weight with tirzepatide, whereas the placebo group achieved only 9.9%. Maintaining weight loss has always bee